Title: Summary of Significant Accounting Policies
Accounting Policies: (1) The accompanying Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) presents the activity of all federal programs and state projects of the Corporation for the year ended June 30, 2023. All expenditures related to federal awards and state projects received directly from federal and state agencies, as well as federal awards and state projects passed through other governmental agencies, are included in the accompanying Schedule. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). (2) The Schedule was prepared on the accrual basis of accounting. (3) There were no transfers to subrecipients during the fiscal year ended June 30, 2023. (4) There were no federal awards expended in non-cash assistance. (5) The Corporation elected not to use the 10% de minimis indirect cost rate. (6) Expenditures in the amount of $361,462 shown for the COVID-19 Provider Relief Funds, CFDA #93.498, were incurred during the year ended June 30, 2022 and are based upon the February 17, 2023 PRF report.
De Minimis Rate Used: N
Rate Explanation: The Corporation elected not to use the 10% de minimis indirect cost rate.
(1) The accompanying Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) presents the activity of all federal programs and state projects of the Corporation for the year ended June 30, 2023. All expenditures related to federal awards and state projects received directly from federal and state agencies, as well as federal awards and state projects passed through other governmental agencies, are included in the accompanying Schedule. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance).
Title: Basis of Accounting
Accounting Policies: (1) The accompanying Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) presents the activity of all federal programs and state projects of the Corporation for the year ended June 30, 2023. All expenditures related to federal awards and state projects received directly from federal and state agencies, as well as federal awards and state projects passed through other governmental agencies, are included in the accompanying Schedule. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). (2) The Schedule was prepared on the accrual basis of accounting. (3) There were no transfers to subrecipients during the fiscal year ended June 30, 2023. (4) There were no federal awards expended in non-cash assistance. (5) The Corporation elected not to use the 10% de minimis indirect cost rate. (6) Expenditures in the amount of $361,462 shown for the COVID-19 Provider Relief Funds, CFDA #93.498, were incurred during the year ended June 30, 2022 and are based upon the February 17, 2023 PRF report.
De Minimis Rate Used: N
Rate Explanation: The Corporation elected not to use the 10% de minimis indirect cost rate.
(2) The Schedule was prepared on the accrual basis of accounting.
Title: Transfers to Subrecipients
Accounting Policies: (1) The accompanying Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) presents the activity of all federal programs and state projects of the Corporation for the year ended June 30, 2023. All expenditures related to federal awards and state projects received directly from federal and state agencies, as well as federal awards and state projects passed through other governmental agencies, are included in the accompanying Schedule. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). (2) The Schedule was prepared on the accrual basis of accounting. (3) There were no transfers to subrecipients during the fiscal year ended June 30, 2023. (4) There were no federal awards expended in non-cash assistance. (5) The Corporation elected not to use the 10% de minimis indirect cost rate. (6) Expenditures in the amount of $361,462 shown for the COVID-19 Provider Relief Funds, CFDA #93.498, were incurred during the year ended June 30, 2022 and are based upon the February 17, 2023 PRF report.
De Minimis Rate Used: N
Rate Explanation: The Corporation elected not to use the 10% de minimis indirect cost rate.
(3) There were no transfers to subrecipients during the fiscal year ended June 30, 2023.
Title: Non-Cash Assistance
Accounting Policies: (1) The accompanying Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) presents the activity of all federal programs and state projects of the Corporation for the year ended June 30, 2023. All expenditures related to federal awards and state projects received directly from federal and state agencies, as well as federal awards and state projects passed through other governmental agencies, are included in the accompanying Schedule. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). (2) The Schedule was prepared on the accrual basis of accounting. (3) There were no transfers to subrecipients during the fiscal year ended June 30, 2023. (4) There were no federal awards expended in non-cash assistance. (5) The Corporation elected not to use the 10% de minimis indirect cost rate. (6) Expenditures in the amount of $361,462 shown for the COVID-19 Provider Relief Funds, CFDA #93.498, were incurred during the year ended June 30, 2022 and are based upon the February 17, 2023 PRF report.
De Minimis Rate Used: N
Rate Explanation: The Corporation elected not to use the 10% de minimis indirect cost rate.
(4) There were no federal awards expended in non-cash assistance.
Title: Federal Indirect Rate
Accounting Policies: (1) The accompanying Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) presents the activity of all federal programs and state projects of the Corporation for the year ended June 30, 2023. All expenditures related to federal awards and state projects received directly from federal and state agencies, as well as federal awards and state projects passed through other governmental agencies, are included in the accompanying Schedule. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). (2) The Schedule was prepared on the accrual basis of accounting. (3) There were no transfers to subrecipients during the fiscal year ended June 30, 2023. (4) There were no federal awards expended in non-cash assistance. (5) The Corporation elected not to use the 10% de minimis indirect cost rate. (6) Expenditures in the amount of $361,462 shown for the COVID-19 Provider Relief Funds, CFDA #93.498, were incurred during the year ended June 30, 2022 and are based upon the February 17, 2023 PRF report.
De Minimis Rate Used: N
Rate Explanation: The Corporation elected not to use the 10% de minimis indirect cost rate.
(5) The Corporation elected not to use the 10% minimis indirect cost rate.
Title: Provider Relief Fund
Accounting Policies: (1) The accompanying Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) presents the activity of all federal programs and state projects of the Corporation for the year ended June 30, 2023. All expenditures related to federal awards and state projects received directly from federal and state agencies, as well as federal awards and state projects passed through other governmental agencies, are included in the accompanying Schedule. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). (2) The Schedule was prepared on the accrual basis of accounting. (3) There were no transfers to subrecipients during the fiscal year ended June 30, 2023. (4) There were no federal awards expended in non-cash assistance. (5) The Corporation elected not to use the 10% de minimis indirect cost rate. (6) Expenditures in the amount of $361,462 shown for the COVID-19 Provider Relief Funds, CFDA #93.498, were incurred during the year ended June 30, 2022 and are based upon the February 17, 2023 PRF report.
De Minimis Rate Used: N
Rate Explanation: The Corporation elected not to use the 10% de minimis indirect cost rate.
(6) Expenditures in the amount of $361,462 shown for the COVID-19 Provider Relief Funds, CFDA #93.498, were incurred during the year ended June 30, 2022 and are based upon the February 17, 2023 PRF report.